Founder: Isaac Litman (CEO)
Funding: $19 million
Valuation: $49 million
Key technologies: Artificial intelligence, biochips, cloud computing, deep learning, Internet of Things, machine learning
Industry: Health care
Previous appearances on Disruptor 50 List: 1 (No. 9 in 2020)
The Covid-19 pandemic accelerated the adoption of telemedicine, and with it emphasized the benefits of being able to monitor health symptoms at a distance. Enter Neteera, a health-care technology firm that makes in-room sensors providing contact-free, continuous monitoring of cardiovascular and respiratory vital signs. The company is pursuing a variety of use cases for the sensors, from detecting sleep apnea, to preventing post-operative complications, to screening for infectious disease symptoms in high-density public places like airports and shopping malls.
The Jerusalem-based company has been named a critical technology in the fight against Covid-19 by the Israeli Ministry of Defense. Neteera has been working with hospitals in Israel, as well as in France, to study the sensors' ability to predict whether a patient has Covid, or other infectious diseases. The findings are expected to be published later this month, according to founder & CEO Isaac Litman.
Litman is the former CEO of self-driving technology company Mobileye, which he led for six years and shepherded to an IPO in 2014 (it later sold to Intel for $15.3 billion). Neteera has raised $16.7 million to date. Northwell Ventures, the venture capital arm of hospital operator Northwell Health, participated in its most recent funding round in 2019.
—Contributed by David Spiegel
SIGN UP for our weekly, original newsletter that goes beyond the list, offering a closer look at CNBC Disruptor 50 companies, and the founders who continue to innovate across every sector of the economy.